Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Werewolf Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 42 | 51 | +9 |
| Shares | 19.0M | 19.1M | +132.8K (+0.7%) |
| Value | $326.2M | $228.3M | −$98.0M (−30.0%) |
New holders (12)
Institutions that held Werewolf Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 22,034 | $262.0K | 0.00% |
| Rhumbline Advisers | 19,305 | $230.0K | 0.00% |
| Granite Point Capital Management, L.P. | 15,000 | $179.0K | 0.07% |
| Manufacturers Life Insurance Company, The | 12,831 | $153.0K | 0.00% |
| Wells Fargo & Company | 12,699 | $151.0K | 0.00% |
| Susquehanna International Group, LLP | 11,829 | $141.0K | 0.00% |
| MetLife Investment Management | 11,421 | $136.0K | 0.00% |
| Goldman Sachs Group Inc | 10,080 | $120.0K | 0.00% |
| Metropolitan Life Insurance Co | 8,460 | $100.8K | 0.00% |
| High Net Worth Advisory Group LLC | 500 | $6.00K | 0.00% |
| Daiwa Securities Group Inc. | 80 | $1.00K | 0.00% |
| Confluence Wealth Services, Inc. | 100 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Werewolf Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Nicholas Investment Partners, LP | 296,283 | $5.08M |
| Russell Investments Group, Ltd. | 125,873 | $2.16M |
| Levin Capital Strategies, L.P. | 15,000 | $257.0K |